Annual ROE
-92.18%
+57.45%+38.39%
31 December 2023
Summary:
Madrigal Pharmaceuticals annual return on equity is currently -92.18%, with the most recent change of +57.45% (+38.39%) on 31 December 2023. During the last 3 years, it has fallen by -7.90% (-9.37%). MDGL annual ROE is now -129.03% below its all-time high of 317.48%, reached on 31 December 2009.MDGL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-89.04%
+24.95%+21.89%
30 September 2024
Summary:
Madrigal Pharmaceuticals quarterly return on equity is currently -89.04%, with the most recent change of +24.95% (+21.89%) on 30 September 2024. Over the past year, it has increased by +269.82% (+75.19%). MDGL quarterly ROE is now -102.52% below its all-time high of 3532.29%, reached on 31 March 2010.MDGL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.4% | +75.2% |
| 3 y3 years | -9.4% | +2.4% |
| 5 y5 years | -1239.8% | -512.0% |
MDGL ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.4% | +38.4% | at high | +75.2% |
| 5 y | 5 years | -1239.8% | +38.4% | -512.0% | +75.2% |
| alltime | all time | -129.0% | +83.2% | -102.5% | +93.5% |
Madrigal Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -89.04%(-21.9%) |
| June 2024 | - | -113.99%(-21.4%) |
| Mar 2024 | - | -145.00%(-31.8%) |
| Dec 2023 | -92.18%(-38.4%) | -212.62%(-40.8%) |
| Sept 2023 | - | -358.86%(+18.7%) |
| June 2023 | - | -302.44%(+12.9%) |
| Mar 2023 | - | -267.87%(+14.9%) |
| Dec 2022 | -149.63%(+21.3%) | -233.13%(+14.2%) |
| Sept 2022 | - | -204.19%(+48.6%) |
| June 2022 | - | -137.44%(+23.4%) |
| Mar 2022 | - | -111.39%(+10.7%) |
| Dec 2021 | -123.32%(+46.3%) | -100.59%(+10.3%) |
| Sept 2021 | - | -91.23%(+10.7%) |
| June 2021 | - | -82.38%(+14.4%) |
| Mar 2021 | - | -71.99%(+19.2%) |
| Dec 2020 | -84.28%(+318.3%) | -60.38%(+32.5%) |
| Sept 2020 | - | -45.56%(+38.5%) |
| June 2020 | - | -32.89%(+35.8%) |
| Mar 2020 | - | -24.22%(+30.4%) |
| Dec 2019 | -20.15%(+192.9%) | -18.58%(+27.7%) |
| Sept 2019 | - | -14.55%(+26.0%) |
| June 2019 | - | -11.55%(+16.3%) |
| Mar 2019 | - | -9.93%(+9.2%) |
| Dec 2018 | -6.88%(-59.7%) | -9.09%(-15.6%) |
| Sept 2018 | - | -10.77%(-30.1%) |
| June 2018 | - | -15.41%(-50.1%) |
| Mar 2018 | - | -30.91%(-26.8%) |
| Dec 2017 | -17.09%(-76.4%) | -42.21%(-37.8%) |
| Sept 2017 | - | -67.87%(-20.5%) |
| June 2017 | - | -85.38%(+8.2%) |
| Mar 2017 | - | -78.91%(-33.6%) |
| Dec 2016 | -72.47%(-618.0%) | -118.87%(+56.3%) |
| Sept 2016 | - | -76.03%(+205.7%) |
| June 2016 | - | -24.87%(-66.3%) |
| Mar 2016 | - | -73.71%(-36.0%) |
| Dec 2015 | 13.99%(-110.6%) | -115.25%(+19.3%) |
| Sept 2015 | - | -96.59%(-19.2%) |
| June 2015 | - | -119.57%(-11.8%) |
| Mar 2015 | - | -135.59%(-2.4%) |
| Dec 2014 | -132.28% | -138.89%(-19.8%) |
| Sept 2014 | - | -173.25%(-20.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | -218.87%(-8.7%) |
| Mar 2014 | - | -239.79%(+22.7%) |
| Dec 2013 | -183.72%(+31.4%) | -195.38%(-0.7%) |
| Sept 2013 | - | -196.70%(+12.8%) |
| June 2013 | - | -174.36%(+11.1%) |
| Mar 2013 | - | -156.97%(-11.9%) |
| Dec 2012 | -139.78%(-43.6%) | -178.11%(-19.1%) |
| Sept 2012 | - | -220.27%(+7.8%) |
| June 2012 | - | -204.37%(-1.7%) |
| Mar 2012 | - | -208.01%(-1.3%) |
| Dec 2011 | -247.72%(+60.0%) | -210.82%(+14.9%) |
| Sept 2011 | - | -183.52%(+15.1%) |
| June 2011 | - | -159.45%(+14.3%) |
| Mar 2011 | - | -139.54%(+14.4%) |
| Dec 2010 | -154.85%(-148.8%) | -122.00%(+10.0%) |
| Sept 2010 | - | -110.87%(-111.0%) |
| June 2010 | - | 1005.82%(-71.5%) |
| Mar 2010 | - | 3532.29%(-1372.4%) |
| Dec 2009 | 317.48%(+101.5%) | -277.61%(+128.0%) |
| Sept 2009 | - | -121.77%(-195.1%) |
| June 2009 | - | 128.11%(-39.9%) |
| Mar 2009 | - | 213.20%(-46.5%) |
| Dec 2008 | 157.54%(-128.7%) | 398.84%(-129.0%) |
| Sept 2008 | - | -1375.78%(+354.8%) |
| June 2008 | - | -302.47%(+83.6%) |
| Mar 2008 | - | -164.70%(-4.4%) |
| Dec 2007 | -548.58%(+143.0%) | -172.34%(-3.3%) |
| Sept 2007 | - | -178.16%(+9.6%) |
| June 2007 | - | -162.52%(+30.5%) |
| Mar 2007 | - | -124.52%(-10.3%) |
| Dec 2006 | -225.78%(+179.4%) | -138.81%(+27.9%) |
| Sept 2006 | - | -108.50%(-21.0%) |
| June 2006 | - | -137.27%(-14.0%) |
| Mar 2006 | - | -159.67%(+41.4%) |
| Dec 2005 | -80.81%(+71.4%) | -112.96%(+60.3%) |
| Sept 2005 | - | -70.48%(+59.9%) |
| June 2005 | - | -44.07%(+149.4%) |
| Mar 2005 | - | -17.67% |
| Dec 2004 | -47.15%(-32.7%) | - |
| Dec 2003 | -70.01%(+404.4%) | - |
| Dec 2001 | -13.88% | - |
FAQ
- What is Madrigal Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual ROE year-on-year change?
- What is Madrigal Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly ROE year-on-year change?
What is Madrigal Pharmaceuticals annual return on equity?
The current annual ROE of MDGL is -92.18%
What is the all time high annual ROE for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual return on equity is 317.48%
What is Madrigal Pharmaceuticals annual ROE year-on-year change?
Over the past year, MDGL annual return on equity has changed by +57.45% (+38.39%)
What is Madrigal Pharmaceuticals quarterly return on equity?
The current quarterly ROE of MDGL is -89.04%
What is the all time high quarterly ROE for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly return on equity is 3532.29%
What is Madrigal Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, MDGL quarterly return on equity has changed by +269.82% (+75.19%)